Annotated Medicine and Device Lists
| List | Section | Observation |
|---|---|---|
| Colombia. "Listado de Medicamentos del Plan de Beneficios en Salud con Cargo a la UPC" 2016 | Listado de Medicamentos del Plan de Beneficios en Salud con cargo a la UPC |
Others observations: INCLUYE TODAS LAS CONCENTRACIONES Y FORMAS FARMACÉUTICAS |
| Argentina. FTN COMRA. Confederacion Medica de la Rep. Argentina. 2018 | 05.02. OTROS FARMACOS ANTIRREUMATICOS | No observations |
| Argentina. FTN COMRA. Confederacion Medica de la Rep. Argentina. 2018 | 18.05 FÁRMACOS QUE AFECTAN LA RESPUESTA INMUNE-INMUNOSUPRESORES | No observations |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 8.1. Immunosuppressive medicines | No observations |
| PAHO Strategic Fund Medicine List | 3.1. Immunosuppressive med. |
Others observations: Limited supply options (normally, none or only one supplier identified / prequalified); may result in longer delivery times. |
| Ecuador | Essential Medicines List - Ecuador | No observations |
| Belize. National Drug Formulary | 08.01 Immunosuppressive medicines | No observations |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 8.1. Immunosuppressive medicines | No observations |
| Barbados. Barbados National Drug Formulary (BNDF) | 10.0 Antineoplastics | No observations |
| Bahamas. Drug Formulary | 10. ANTINEOPLASTIC AND RELATED AGENTS | No observations |
| Belize. National Drug Formulary | 02.04 Chronic gout | No observations |
| Belize. National Drug Formulary | 08.01 Immunosuppressive medicines | No observations |
| Cayman Islands Health Services Authority Pharmacy Drug Formulary | 08.02.01 Antiproliferative Immunosupressants | No observations |
| Cayman Islands Health Services Authority Pharmacy Drug Formulary | Drugs affecting the immune system | No observations |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 29.2 Disease-modifying anti-rheumatic drugs (DMARDs) | No observations |
| Cuba. Cuadro Básico de Medicamentos 2018. Ministerio de Salud Pública. | CUADRO BÁSICO DE MEDICAMENTOS 2018. Ministerio de Salud Pública. |
Others observations: X 100 TABLETAS |
| Costa Rica. Caja Costarricense de Seguro Social. 2019 | 41. Antineoplásicos y agentes inmunomoduladores | No observations |
| Jamaica. List of Vital Essential and Necessary Drugs and Medical Sundries for Public Health Institutions. 2015 | 08.07 IMMUNOSUPPRESSANTS | No observations |
| Mexico. Cuadro Basico de Medicamentos - 2017 | 21. REUMATOLOGIA Y TRAUMATOLOGIA | No observations |
| Brasil. Relação Nacional de Medicamentos Essenciais. 2020 | L. AGENTES ANTINEOPLÁSICOS E IMUNOMODULADORES | No observations |
| Paraguay. Lista de Medicamentos Esenciales. 2009 | 04. INMUNOSUPRESORES | No observations |
| El Salvador - 2019 | INMUNOMODULADORES | No observations |
| Chile. Formulario Nacional de Medicamentos. 2005 | 02.04. ANTIRREUMATICOS NO ESTEROIDALES | No observations |
| Chile. Formulario Nacional de Medicamentos. 2005 | 07.02. INMUNOSUPRESORES | No observations |
| Guyana. Essential Medicines List. 2020-2021 | Reserved for specialist use |
Others observations: Reserved for specialist use. |
| Guyana. Essential Medicines List. 2020-2021 | 9.02.06. Immunosupressants | No observations |
| Organisation of Eastern Caribbean States. Medical Products List. 2019-2021 | 10:00 Anti-neoplastic agents | No observations |
| Suriname. NGK-C-011 | 2.4 Anti-gout agents and agents for Rheumatic diseases | No observations |
| Suriname. NGK-C-011 | 8.1 Immunosuppressants | No observations |
| Haiti. National List of Essential Medicines | 30.02. Disease modifying agents used in rheumatoid arthritis | No observations |